#biotech startups

Are gene-editing startups overhyped given current clinical trial failures?

Would you ever trust a biotech startup that skips basic research for faster product development?

Do synthetic biology startups add real value, or mostly hype hoping for a patent sell-off?

Should you still invest in biotech startups after recent supply chain disruptions?

Are you a science snob if you look down on biotech startups that haven’t published a single paper?